Centenaire Biosciences
Centenaire Biosciences is a biopharmaceutical company that develops new drugs for cancer, immune diseases, and brain nerve diseases.
Centenaire Biosciences is a business in biopharma, manufacturing, medical based in Asia-Pacific (APAC), founded in 2021.
The company sits in the biopharma, manufacturing, medical segment, where it competes on its core product or service.
The business is associated with Asia-Pacific (APAC).
Its current recorded stage is Series_A.
Recorded headcount: c_00001_00010 employees.
Public records show total funding of about $20B.
| Sector | Biopharma, Manufacturing, Medical |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2021 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $20,000,000,000 |
Website: www.ctnbio.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account